Cited by 1,433Genomics and Phylogenetic StudiesGenomics and Rare DiseasesGenomic variations and chromosomal abnormalities

Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing

Open access
Gnirke, Andreas, Melnikov, Alexandre, Maguire, Jared, Rogov, Peter, LeProust, Emily M, Brockman, William, Fennell, Timothy, Giannoukos, Georgia +6 more·2009·Nature Biotechnology

Abstract

Targeting genomic loci by massively parallel sequencing requires new methods to enrich templates to be sequenced. We developed a capture method that uses biotinylated RNA 'baits' to fish targets out of a 'pond' of DNA fragments. The RNA is transcribed from PCR-amplified oligodeoxynucleotides originally synthesized on a microarray, generating sufficient bait for multiple captures at concentrations high enough to drive the hybridization. We tested this method with 170-mer baits that target >15,000 coding exons (2.5 Mb) and four regions (1.7 Mb total) using Illumina sequencing as read-out. About 90% of uniquely aligning bases fell on or near bait sequence; up to 50% lay on exons proper. The uniformity was such that approximately 60% of target bases in the exonic 'catch', and approximately 80% in the regional catch, had at least half the mean coverage. One lane of Illumina sequence was sufficient to call high-confidence genotypes for 89% of the targeted exon space.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nbt.1523

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In genome research, an average sequence coverage depth of 30-fold has been accepted as sufficient for detecting single-nucleotide polymorphisms and nucleotide insertions or deletions.

    “In genome research, an average depth of sequence coverage of 30-fold has been accepted as sufficient for single-nucleotide polymorphism (SNP) and nucleotide insertion or deletion (indel) detection (15–22).”

    From Carrier testing for severe childhood recessive diseases by next-generation sequencing (2011) · cites this paper as [15]

    The Results (Accuracy of SNP detection; page not provided) say SNP-detection sensitivity is mainly limited by sequence coverage. The paper does not identify 30-fold average coverage as a sufficient threshold, and the Methods (Computational methods; page not provided) state that insertions and deletions were not considered. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Target capture and next-generation sequencing have shown efficacy and, recently, scalability for resequencing human genomes and exomes.

    “Target capture and next-generation sequencing (NGS) have shown efficacy and, recently, scalability for resequencing human genomes and exomes, providing an alternative potential paradigm for comprehensive carrier testing (15–22).”

    From Carrier testing for severe childhood recessive diseases by next-generation sequencing (2011) · cites this paper as [15]

    The Results (Capturing and sequencing exon targets; Reproducibility, pages unavailable) demonstrate capture and next-generation sequencing of more than 15,000 human coding exons, with high-confidence genotypes across most of the targeted space. The introductory text reports that whole human genomes had been sequenced with next-generation instruments. The paper does not demonstrate target capture at whole-exome or whole-genome scale, so the scalability claim is supported for large targeted subsets rather than those complete targets. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Preliminary experiments suggested that Agilent SureSelect hybrid capture and RainDance microdroplet polymerase chain reaction, but not Febit HybSelect microarray-based capture or Olink padlock probe ligation and PCR, yielded consistent target enrichment.

    “Preliminary experiments suggested that existing protocols for Agilent SureSelect hybrid capture (15) and RainDance microdroplet polymerase chain reaction (PCR) (16) but not Febit HybSelect microarray-based biochip capture (30) or Olink padlock probe ligation and PCR (31) yielded consistent target enrichment.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gnirke, A., Melnikov, A., Maguire, J., Rogov, P., LeProust, E. M., Brockman, W., Fennell, T., Giannoukos, G., Fisher, S., Russ, C., Gabriel, S., Jaffe, D. B., Lander, E. S., & Nusbaum, C.
Affiliations
  • Broad Institute (US)
  • Agilent Technologies (United States) (US)
Corresponding author
Gnirke, Andreas
Venue
Nature Biotechnology
Published
2009-02
Volume
27
Issue
2
Pages
182-189
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W2121531763
Cited by
1,433
References
25
Citations by year
2026: 23 · 2025: 48 · 2024: 70 · 2023: 54 · 2022: 56 · 2021: 64 · 2020: 67 · 2019: 70 · 2018: 86 · 2017: 85 · 2016: 105 · 2015: 108 · 2014: 105 · 2013: 110 · 2012: 130
FWCI
51.05
Type
journal article
Language
en
Open access
Locations
  • Nature Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Broad Institute
  • National Human Genome Research Institute (U54HG003067, HG03067-05)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
targeted sequencing, DNA capture, exon capture, next-generation sequencing, genotype calling, human genome
MeSH terms
Base Composition, Bayes Theorem, Exons, Humans, Nucleic Acid Hybridization, Oligonucleotides, Sensitivity and Specificity, Reproducibility of Results, Polymerase Chain Reaction, Sequence Analysis, DNA, Biotinylation, Oligonucleotide Array Sequence Analysis, Polymorphism, Single Nucleotide, Genomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review